Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment

Clinical trial NCT06374485 · RECRUITING

Trial details

NCT number: NCT06374485
Sponsor: Lee's Pharmaceutical Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2024-05-21
Primary completion: 2025-12-28
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.